ALCON AG ALC 深 沪
已收盘 10-31 16:00:00 美东时间
73.89
-0.370
-0.50%
华盛通- 最 高74.66
- 今 开74.42
- 成交量 142.74万股
- 最 低 73.87
- 昨 收 74.26
- 总市值 365.76亿
- 52周最高 98.8664
- 市盈率 静 36.11
- 换手率 0.29%
- 52周最低 71.55
- 委 比 82.75%
- 总股本 4.95亿
- 历史最高 100.7664
- 量 比 0.99
- 振 幅 1.06%
- 历史最低 38.2212
- 每 手 1
- 风险率 5.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多STAAR Surgical gains as Alcon vote said to be adjourned
STAAR Surgical (NASDAQ:STAA) rose 4.4% after the shareholder vote for its planned sale to Alcon (NYSE:ALC) was adjourned. The vote was adjourned until Nov. 6, according to traders. The adjournment c...
10-23 23:43
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
Broadwood, ISS, Glass Lewis, And Egan-Jones To Oppose STAAR Surgical's Proposed Sale; Telling Shareholders To Vote 'Against' Acquisition Over Flawed Process, Timing, and Price
Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood's Concerns over Deeply Deficient Sale Process, Timing, and PriceShareholders Representing More than 34% of
10-20 20:45
STAAR Surgical says no other acqusition proposals other than Alcon
STAAR Surgical (NASDAQ:STAA) said it has not received any proposal to acquire the company other than from Alcon (NYSE:ALC), including the 45-day "window shop" period. "As previously disclosed, the com...
10-17 04:58
Alcidion Withdraws Resolution on Placement Facility Ahead of AGM
Alcidion Group Limited ( ($AU:ALC) ) just unveiled an update. Alcidion Group Li...
10-14 13:17
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
BTIG Maintains Buy on Alcon, Lowers Price Target to $91
BTIG analyst Ryan Zimmerman maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $92 to $91.
10-13 20:08
Defender Capital Opposes Alcon's $28/Share Acquisition Of STAAR, Citing Undervaluation
Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the
10-07 23:30
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
CHARLOTTE, N.C., Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approx...
10-07 23:25
Associated Alcohols & Breweries Opens Special Window for Share Transfer Requests
Associated Alcohols & Breweries Ltd. ( ($IN:ASALCBR) ) has provided an upda...
10-04 20:25
